Oct192026

UK regulator brings new AI and MedTech agenda to AdvaMed

UK’s Medicines and Healthcare products Regulatory Agency (MHRA) sets out its next phase of MedTech and AI regulation to US industry leaders at AdvaMed 2026.

Leave a Reply

Your email address will not be published.